Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Disease to Soft Tissue”

221 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 221 results

Early research (Phase 1)Study completedNCT03150810
What this trial is testing

Study to Assess Safety, Tolerability and Clinical Activity of BGB-290 in Combination With Temozolomide (TMZ) in Participants With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Locally Advanced or Metastatic Solid Tumors
BeiGene 139
Testing effectiveness (Phase 2)Study completedNCT02066675
What this trial is testing

Trabectedin First Line Therapy In Unfit Sarcoma Study

Who this might be right for
Metastatic and Locally Advanced Soft Tissue Tumor Patients Unfit to ReceiveStandard Chemotherapy
Italian Sarcoma Group 24
Testing effectiveness (Phase 2)Study completedNCT00060944
What this trial is testing

Assess Treatment With 2 Different Dosing Schedules of Trabectidin Administered to Patients With Advanced Cancer

Who this might be right for
LiposarcomaLeiomyosarcoma
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 271
Early research (Phase 1)Study completedNCT02180698
What this trial is testing

TLR4 Agonist GLA-SE and Radiation Therapy in Treating Patients With Soft Tissue Sarcoma That Is Metastatic or Cannot Be Removed by Surgery

Who this might be right for
Stage III Adult Soft Tissue SarcomaStage IV Adult Soft Tissue Sarcoma
Fred Hutchinson Cancer Center 16
Not applicableLooking for participantsNCT01050504
What this trial is testing

Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer

Who this might be right for
Localized Renal Pelvis and Ureter Urothelial CarcinomaMalignant Solid NeoplasmMetastatic Malignant Neoplasm in the Bone+8 more
University of Washington 1,500
Testing effectiveness (Phase 2)Ended earlyNCT02609984
What this trial is testing

Study to Compare the Safety and Efficacy of CMB305 With Atezolizumab to Atezolizumab Alone in Participants With Sarcoma (IMDZ-C232/V943A-002)

Who this might be right for
SarcomaMyxoid/Round Cell LiposarcomaSynovial Sarcoma+4 more
Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 89
Early research (Phase 1)UnknownNCT03002805
What this trial is testing

CBT-1® in Combination With Doxorubicin in Patients With Metastatic, Unresectable Sarcomas Who Previously Progressed on Doxorubicin

Who this might be right for
Sarcoma
CBA Research 46
Testing effectiveness (Phase 2)Ended earlyNCT04171700
What this trial is testing

Evaluate Rucaparib in Participants With Solid Tumors and With Deleterious Mutations in HRR Genes

Who this might be right for
Solid Tumor
pharmaand GmbH 83
Large-scale testing (Phase 3)WithdrawnNCT00334867
What this trial is testing

Combination Chemotherapy With or Without Topotecan in Treating Patients With Newly Diagnosed Localized Ewing's Sarcoma

Who this might be right for
Sarcoma
Children's Oncology Group
Testing effectiveness (Phase 2)UnknownNCT00637637
What this trial is testing

External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases

Who this might be right for
Cancer
Oncology Institute of Southern Switzerland 60
Large-scale testing (Phase 3)UnknownNCT04741438
What this trial is testing

Efficacy of the Combination of Nivolumab and Ipilimumab as a Treatment in Patients With Sarcoma of Rare Subtype

Who this might be right for
Sarcoma
Centre Leon Berard 96
Testing effectiveness (Phase 2)Study completedNCT00055952
What this trial is testing

Exatecan Mesylate in Treating Patients With Ewing's Sarcoma, Primitive Neuroectodermal Tumor, or Desmoplastic Small Round Cell Tumor

Who this might be right for
Sarcoma
Daiichi Sankyo
Early research (Phase 1)WithdrawnNCT03612466
What this trial is testing

A Dose Finding Study of CycloSam® Combined With External Beam Radiotherapy

Who this might be right for
OsteosarcomaBone Metastases
Albert Einstein College of Medicine
Not applicableStudy completedNCT03977818
What this trial is testing

Patterns of Care and Outcomes in METAstatic Soft Tissue SARComa

Who this might be right for
SarcomaMetastasesChemotherapy
Institut Bergonié 2,165
Testing effectiveness (Phase 2)Study completedNCT00503295
What this trial is testing

Safety and Efficacy Study of REOLYSIN® in the Treatment of Bone and Soft Tissue Sarcomas Metastatic to the Lung

Who this might be right for
OsteosarcomaEwing Sarcoma Family TumorsMalignant Fibrous Histiocytoma+3 more
Oncolytics Biotech 53
Testing effectiveness (Phase 2)Study completedNCT03317457
What this trial is testing

Durvalumab and Tremelimumab Compared to Doxorubicin in Patients With Advanced or Metastatic Soft Tissue Sarcoma

Who this might be right for
Metastatic Adult Soft Tissue SarcomaRecurrent Adult Soft Tissue Sarcoma
AIO-Studien-gGmbH 103
Post-approval studies (Phase 4)Study completedNCT00756509
What this trial is testing

Treatment of Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumors in First Line With Nilotinib

Who this might be right for
Gastrointestinal Stromal Tumors
Novartis Pharmaceuticals 34
Not applicableStudy completedNCT00976612
What this trial is testing

Nilotinib Pharmacokinetics (PK) in Gastrointestinal Stromal Tumor (GIST): Nilotinib PK

Who this might be right for
Gastrointestinal Stromal Tumors
Asan Medical Center 17
Testing effectiveness (Phase 2)Study completedNCT00330421
What this trial is testing

Sorafenib in Treating Patients With Soft Tissue Sarcomas (Extremity Sarcoma Closed to Entry as of 5/30/07)

Who this might be right for
Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal TumorMetastatic OsteosarcomaRecurrent Adult Soft Tissue Sarcoma+6 more
National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)Study completedNCT01055314
What this trial is testing

Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma

Who this might be right for
Adult RhabdomyosarcomaChildhood Alveolar RhabdomyosarcomaChildhood Embryonal Rhabdomyosarcoma+3 more
National Cancer Institute (NCI) 175
Next Page